Moderna’s AI-Built Cancer Vaccine Clears Phase 3 With Merck

Moderna built an artificial intelligence that reads a patient’s tumor and decides what that patient’s medicine should be. That approach just cleared its biggest test. Moderna and Merck announced Aug.